Isoindolin-1-one derivatives

Details for Australian Patent Application No. 2005278962 (hide)

Owner Cancer Research Technology Limited

Inventors Hardcastel, Ian Robert; Golding, Bernard Thomas; Calvert, Alan H.; Nobel, Martin E. M.; Willems, Hendrika Maria Gerarda; Griffin, Roger John; Lunec, John; Newell, David R.; Kallblad, Per

Agent Fisher Adams Kelly

Pub. Number AU-B-2005278962

PCT Pub. Number WO2006/024837

Priority 0419481.7 02.09.04 GB

Filing date 26 August 2005

Wipo publication date 9 March 2006

Acceptance publication date 1 March 2012

International Classifications

C07D 209/48 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61P 35/00 (2006.01) Antineoplastic agents

C07D 209/50 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/024837 Priority application(s): WO2006/024837

1 March 2012 Application Accepted

  Published as AU-B-2005278962

14 June 2012 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to read Hardcastele, Ian Robert; Golding, Bernard Thomas; Calvert, Alan H.; Nobel, Martin E. M.; Willems, Hendrika Maria Gerarda; Griffin, Roger John; Lunec, John; Newell, David R. and Kallblad, Per. Address for service in Australia - Fisher Adams Kelly Level 29 12 Creek Street Brisbane QLD 4000

28 June 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 29 May 2012 . Address for service in Australia - Fisher Adams Kelly Level 29 12 Creek Street Brisbane QLD 4000

4 October 2012 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to read Willems, Hendrika Maria Gerarda; Kallblad, Per; Hardcastle, Ian Robert; Griffin, Roger John; Golding, Bernard Thomas; Lunec, John; Nobel, Martin E. M.; Newell, David R. and Calvert, Alan H. . Address for service in Australia - Fisher Adams Kelly Level 29 12 Creek Street Brisbane QLD 4000

25 October 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 29 May 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005278966-Benzamide compounds

2005278961-Quinazolinone derivatives and their use as B-Raf inhibitors